A Multicenter Multinational Observational Study of Children With Hypochondroplasia

Description

This study will assess growth over time and the clinical course of HCH in children by collecting growth measurements and other variables of interest.

Conditions

Hypochondroplasia

Talk to us

Study Overview

On this page

Study Details

Study overview

This study will assess growth over time and the clinical course of HCH in children by collecting growth measurements and other variables of interest.

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

Condition
Hypochondroplasia
Intervention / Treatment

-

Contacts and Locations

Phoenix

Phoenix Children's Hospital, Phoenix, Arizona, United States, 85016

Los Angeles

Cedars-Sinai Medical Center, Los Angeles, California, United States, 90048

Oakland

UCSF Benioff Children's Hospital, Oakland, California, United States, 94609

Wilmington

Nemours Alfred I. Dupont Hospital for Children, Wilmington, Delaware, United States, 19803

Washington

Children's National Health System, Washington, District of Columbia, United States, 20010

Chicago

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States, 60611

Baltimore

The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States, 21218

Boston

Boston Children's Hospital, Boston, Massachusetts, United States, 02115

Minneapolis

University of Minnesota Masonic Children's Hospital, Minneapolis, Minnesota, United States, 55454

Columbia

University of Missouri, Columbia, Missouri, United States, 65212

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Participants must be ≤ 15 years old at the time of signing the informed consent
  • * Participants must have genetic confirmation of Hypochondroplasia diagnosis
  • * Have a diagnosis of another genetic short stature condition other than Hypochondroplasia or a genetic variant known to cause another genetic syndrome associated with short stature
  • * Received an investigational product or medical device within 6 months before the Screening visit

Ages Eligible for Study

to 15 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

BioMarin Pharmaceutical,

Medical Director, MD, STUDY_DIRECTOR, BioMarin Pharmaceutical

Study Record Dates

2043-12-31